Gangadhar G. Durgam, Ph.D. - Publications

Affiliations: 
2005 University of Tennessee Health Science Center, Memphis, TN, United States 
Area:
Pharmaceutical Chemistry

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Khandoga AL, Fujiwara Y, Goyal P, Pandey D, Tsukahara R, Bolen A, Guo H, Wilke N, Liu J, Valentine WJ, Durgam GG, Miller DD, Jiang G, Prestwich GD, Tigyi G, et al. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin. Platelets. 19: 415-27. PMID 18925509 DOI: 10.1080/09537100802220468  0.604
2007 Deng W, Shuyu E, Tsukahara R, Valentine WJ, Durgam G, Gududuru V, Balazs L, Manickam V, Arsura M, VanMiddlesworth L, Johnson LR, Parrill AL, Miller DD, Tigyi G. The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury. Gastroenterology. 132: 1834-51. PMID 17484878 DOI: 10.1053/J.Gastro.2007.03.038  0.524
2006 Durgam GG, Tsukahara R, Makarova N, Walker MD, Fujiwara Y, Pigg KR, Baker DL, Sardar VM, Parrill AL, Tigyi G, Miller DD. Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands. Bioorganic & Medicinal Chemistry Letters. 16: 633-40. PMID 16263282 DOI: 10.1016/J.Bmcl.2005.10.031  0.626
2006 Goyal P, Durgam G, Wilke N, Miller D, Tigyi G, Siess W. We-P11:210 Evaluation of novel phosphatidic acid derivatives as antagonists of platelet activation induced by the plaque lipid lysophosphatidic acid Atherosclerosis Supplements. 7: 392. DOI: 10.1016/S1567-5688(06)81564-3  0.535
2005 Durgam GG, Virag T, Walker MD, Tsukahara R, Yasuda S, Liliom K, van Meeteren LA, Moolenaar WH, Wilke N, Siess W, Tigyi G, Miller DD. Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin. Journal of Medicinal Chemistry. 48: 4919-30. PMID 16033271 DOI: 10.1021/Jm049609R  0.663
2004 Gududuru V, Hurh E, Durgam GG, Hong SS, Sardar VM, Xu H, Dalton JT, Miller DD. Synthesis and biological evaluation of novel cytotoxic phospholipids for prostate cancer. Bioorganic & Medicinal Chemistry Letters. 14: 4919-23. PMID 15341952 DOI: 10.1016/J.Bmcl.2004.07.026  0.557
2003 Virag T, Elrod DB, Liliom K, Sardar VM, Parrill AL, Yokoyama K, Durgam G, Deng W, Miller DD, Tigyi G. Fatty alcohol phosphates are subtype-selective agonists and antagonists of lysophosphatidic acid receptors. Molecular Pharmacology. 63: 1032-42. PMID 12695531 DOI: 10.1124/Mol.63.5.1032  0.622
Show low-probability matches.